Background/Aims: Gastric cancer (GC) is a common and lethal malignancy, and AMPactivated protein kinase-related kinase 5 (ARK5) has been discovered to promote cancer metastasis in certain types of cancer. In this study, we explored the role of ARK5 in GC invasion and metastasis. Methods: ARK5 and epithelial-mesenchymal transition (EMT)-related markers were determined by immunohistochemistry and western blot in GC specimens. Other methods including stably transfected against ARK5 into SGC7901 and AGS cells, western blot, migration and invasion assays in vitro and nude mice tumorigenicity in vivo were also employed.
Introduction
Gastric cancer (GC), ranking the fifth most common malignancy [1] and the third in all cancer-related deaths worldwide [2] , remains a global cancer burden, with a considerable amount of morbidity and mortality [3] . Metastasis, a major cause of governing cancer patient mortality, is a complex and multistep process that is still unresolved, despite improvements in surgical treatment and chemotherapy during past decades [4] . Consequently, identification of novel markers participation in the metastatic progression of GC, and understanding of the mechanisms responsible for GC invasion and metastasis, may provide potential therapeutic targets.
More recently, there are accumulating evidence that epithelial-mesenchymal transition (EMT) contributes to cancer cells invasion and metastasis [5] [6] [7] [8] [9] . The term EMT refers to a transdifferentiation process of epithelial cells into mesenchymal cells, in which epithelial cells shed certain features (such as cellular adherence and absence of motility), and gain mesenchymal characteristics (such as motility and invasiveness) [10] . During EMT, the hallmark is the loss of the adhesion molecule biomarker E-cadherin, together with the upregulated expression of Vimentin or N-cadherin. This switch in cell behaviour is controlled by crucial transcription factors, including Slug, Snail, ZEB, SIP1 and Twist, the functions of which are performed at transcriptional level; as well as non-transcriptional factors, such as signaling pathways responding to extracellular cues. As already reported, certain signaling pathways involved in EMT include the AKT/mTOR, Notch, Wnt, TGF-β and AMP-activated protein kinase (AMPK) pathways [5, 11, 12] .
ARK5, known as the fifth member of the human AMPK family, is unique among AMPK catalytic subunit family members on account of its activation directly mediated by Aktdependent phosphorylation at serine residue on the regulatory domain [13] . Akt, one of the most commonly pathways in various types of cancers, is regarded as an important element in facilitating cancer cells proliferation, oncogenesis, survival, invasion and metastasis [14] , and ARK5 is a crucial effector of these actions of Akt. Notably, recent investigations reveal that ARK5 is a critical molecule in promoting the invasion and metastasis of cancer cells in certain human malignancies [15, 16] , including those of hepatocellular carcinoma [17] , colorectal cancer [18] , glioma [19] and non-small cell lung cancer [20] . More importantly, the high expression level of ARK5 in cancer tissues correlates with advanced clinical stage, enhanced metastatic potential and shortened patient survival [17, 19, 20] , indicating that ARK5 may be a valuable prognostic marker in a variety of human malignancies. More recently, an interesting finding demonstrates that ARK5 expression is closely associated with more aggressive cancer characteristics and a poor prognosis for patients with GC [21] , despite its actual role and the underlying mechanism involved in GC invasion and metastasis have not yet been elucidated.
Based on the discussion mentioned above, we investigated in the current study whether ARK5 is involved in GC invasion and metastasis, using clinical samples of patients, human GC cell lines and nude mice.
Materials and Methods

Patients selection and tissue preparation
A total of 82 patients diagnosed with gastric adenocarcinoma who underwent radical gastrectomy at our hospital from January 2011 to March 2012 were enrolled in this study. Among them, fresh tissues of 25 cases were also assessed by western blot for ARK5 protein. None of them received either preoperative chemotherapy or radiotherapy. Primary lesion and corresponding non-cancerous tissue, identified by routine pathological observation, were embedded in paraffin blocks for various immunohistochemical stainings. All patients were followed up until November 2016, with a total of 9 cases (11.0 % patients) lost in follow-up period. Preoperative written consent was obtained from each patient in accordance with the Helsinki Declaration, and this study was also approved by the Ethics Committee of the Fifth Affiliated Hospital of Nantong University.
Immunohistochemistry
Expressions of ARK5, E-cadherin and Vimentin in specimens were determined by immunohistochemistry (IHC) as described previously [7] . We used antibodies against ARK5 (1:200, Abcam, UK), E-cadherin (1:200, CST, USA), and Vimentin (1:100, CST, USA). Sections were observed under the microscope. Two independent pathologists evaluated and scored the sections (double-blinded). The evaluation of staining result was graded as described previously [7] , the percentage of staining cells scores (0 point = 0-5 %; 1 point = 6-25 %; 2 points = 26-50 %; 3 points = more than 50 %) and the staining intensity scores (0 point = negative; 1 point = weak intensity; 2 points = moderate intensity; 3 points = strong intensity) were summed. The sum scores ≥ 3 points was considered as positive, while the sum scores < 3 points was regarded as negative.
Cell culture
The human GC cell lines KATO-III, MKN28, SGC7901, AGS, MKN45 and MGC803 were obtained from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). KATO-III cells were maintained in 80 % IMDM (ATCC, USA) supplemented with 20 % fetal bovine serum (FBS) (Gibco). The other cell lines including MKN28, SGC7901, AGS, MKN45 and MGC803 were cultured in 90 % RPMI-1640 (Gibco) supplemented with 10 % FBS (Gibco). All cells were maintained in a humidified atmosphere of 37 ˚C containing 5 % CO 2 .
Western blot
Western blot was performed using standard technique as described previously [7] . Briefly, Cells were lysed in lysis buffer on ice. Equal amounts of protein were separated by SDS-PAGE and transferred to PVDF membrane (Millipore, USA). Membranes were blocked with 5 % non-fat milk and then incubated with primary antibodies at 4 ˚C overnight. Secondary antibodies were incubated for 2 h at room temperature. Reactive bands were detected using the enhanced chemiluminescence detection kit (Thermo scientific, USA). The primary antibodies were: ARK5 rabbit pAb (1:500, Abcam, UK), p-mTOR rabbit mAb (1:1000, Abcam, UK), mTOR rabbit mAb (1:1000, Abcam, UK), p-p70S6K rabbit pAb (1:1000, Abcam, UK), p70S6K rabbit mAb (1:1000, Abcam, UK), Slug rabbit mAb (1:1000, CST, USA), SIP1 rabbit mAb (1:1000, CST, USA), Snail rabbit mAb (1:1000, CST, USA), ZEB1 rabbit mAb (1:1000, CST, USA), Twist mouse mAb (1:1000, Abcam, UK), E-cadherin rabbit mAb (1:1000, CST, USA), Vimentin rabbit mAb (1:1000, CST, USA), GAPDH mAb-HRP (1:5000, Bioworld Technology, USA).
RNA interference and stably transfected clone selection
Three shRNA oligonucleotides sequences for specifically targeting human ARK5 gene mRNA were designed using the RNAi designer. A nonspecific scrambled shRNA sequence was used as a control. The three shRNA sequence were as follows: the shRNA1 (siRNA1, 5'-GAATGATATCTTGTTGAGCTTGCTGCA-3'); the shRNA2 (siRNA2, 5'-CCAGATAAGCTTGCCACCATGGAAGGGGCCC-3'); the shRNA3 (siRNA3, 5'-CTAGAAGCTTCAGAAGGGGCCGCCGCG-3') [20] . The lentivirus with ARK5-gene was produced by cotransfection of 293T cells with Lipofiter (Hanbio, China). To establish stable ARK5-gene-konckdown cell lines, SGC7901 and AGS cells were infected with concentrated virus in serum-free medium. After 72 h, cells were treated with 2 μg/ml puromycin. Puromycin-resistant clones were collected and expanded for further studies.
Wound healing assay
Cells were grown to 80 % -90 % confluence in a 6-well plate, and a wound was created using a 10 µl plastic tip to produce a straight line. Images were taken at 0 h and 48 h time points to monitor the wound healing process. The wound healing = (0 h width -48 h width)/0 h width × 100 %. Each experiment was performed in triplicate.
Cell migration and invasion assays
Cell migration and invasion assays were performed as described previously [7, 22] . In brief, cells migration and invasion were examined using 8-µm pore size Transwell plates (Corning, USA). Cells (3 × 10 5 ) in 200 μl serum-free medium were added to the upper chamber containing an uncoated or Matrigel TMcoated membrane (BD Biosciences, USA). The lower chamber was filled with 600 μl medium containing 20 % fetal bovine serum as a chemoattractant. After 24 h of incubation, cells on the lower compartment were fixed in paraformaldehyde and stained with crystal violet. Migrated and invaded cells were counted under a microscope. Each experiment was performed in triplicate. 
In vivo tumorigenesis
Male nude athymic BALB/c mice (six-week-old) were used to examine tumorigenicity. To ascertain the role of ARK5 in tumor formation in vivo, the SGC7901 si Ctrl or ARK5 si group cells (3 × 10 6 cells in 0.2 ml volume) were injected subcutaneously into nude mice followed by measurements of the tumor size at 5-day intervals. Tumor size was calculated by the formula: volume = (short diameter) 2 × (long diameter)/2 [7] . At 30 days after injection, the nude mice were sacrificed, and the tumor mass were weighted. To explore the effects of ARK5 on tumor metastasis in vivo, The SGC7901 si Ctrl or ARK5 si group cells (4 × 10 6 cells in 0.2 ml volume) were injected intravenously into the tail vein of nude mice, respectively. After 30 days, the lungs of nude mice were observed by Siemens Inveon Micro PET/CT (Inveon MM platform, Siemens Preclinical Solutions, USA). Afterwards, the mice were sacrificed, and the number of metastatic foci in the lungs of nude mice was calculated. Subsequently, harvested lungs were subjected to further hematoxylin-eosin staining, western blot and IHC staining. The assays were performed using six nude mice per group, and all animal procedures were carried out in accordance with institutional guidelines.
Statistical analysis
The data are expressed as the means ± SD. Statistical analyses of clinicopathologic features were done by Chi-square. Bivariate relations between categorical variables were performed by Spearman's rank correlation coefficient. Kaplan-Meier and Log-rank tests were used for survival analysis. For cell and animal experiments, data were analyzed by Student's t-test or One-Way ANOVA. All the analyses were performed using SPSS 21.0 software (SPSS Inc, USA). P < 0.05 was considered statistically significant.
Results
Clinical significance of ARK5 in patients with GC
Initially, the expression of ARK5 protein was examined in GC tissues and corresponding noncancerous gastric tissues. The result revealed that the higher level of ARK5 protein was expressed in tumor samples than that in Paracancerous tissues (Fig. 1a) . In addition, the expression levels of ARK5, E-cadherin and Vimentin were determined in primary lesion and in adjacent normal gastric mucosas of 82 patients with gastric adenocarcinoma by IHC (Fig. 1b) . As shown in Table 1 , the expression levels of ARK5 and Vimentin in GC tissues were significantly higher than those in adjacent normal gastric mucosa (p = 0.003 and p = 0.042, respectively). In contrast, E-cadherin showed lower expression level in GC tissues (p < 0.001). A clinicopathological association analysis of the 82 patients with gastric adenocarcinoma revealed that the expression levels of ARK5, E-cadherin and Vimentin were closely correlated with T stage, pTNM stage and lymph node metastasis, respectively (p < 0.05) ( Table 2) . Patients who developed lymph node metastasis showed significantly higher staining scores for ARK5 than those without metastasis (p < 0.001) (Fig 1c) , which indicates that ARK5 might play a role in metastasis. More intriguingly, patients with GC, respectively, with ARK5 positive, or Vimentin positive but E-cadherin negative were correlated significantly with shorter overall survival (p < 0.05, respectively) (Fig. 2) . Additionally, Table 3 revealed the expression level of ARK5 was positively correlated with that of Vimentin (r = 0.225, p = 0.043), but inversely related with E-cadherin expression (r = -0.470, p < 0.001) in GC tissues.
Down-regulation of ARK5 in GC cells
To identify the appropriate GC cell lines with high expression level of ARK5, we examined the expression level of ARK5 in the GC cell lines KATO-III, MKN28, SGC7901, AGS, MKN45 and MGC803. SGC7901 and AGS cells showed the highest levels of ARK5 protein expression (Fig. 3a) , and were selected for further studies.
To further confirm the role of ARK5 in GC cells metastasis, three RNA interference expression vectors (siRNA1, siRNA2 and siRNA3) were designed to target human ARK5 in GC cell lines SGC7901 and AGS; meanwhile, a scrambled sequence (si Ctrl) was employed as a control. Obviously, the most widely reduced expression of the siRNA3 group was observed by western blot (Fig. 3b) , which demonstrated that the siRNA3 group had the most efficient knockdown in SGC7901 and AGS cells. Therefore, the GC cell lines SGC7901 and AGS siRNA3 group cells were employed for follow-up assays.
ARK5 modulates EMT, together with the alteration of the mTOR/p70S6k signals, Slug and SIP1 in GC cells
It is acknowledged that E-cadherin, Vimentin and transcription factors are specific biomarkers for the EMT process [5] . To ascertain whether ARK5 knockdown facilitates EMT in GC cell lines, the expression levels of these markers were detected by western blot in SGC7901 and AGS cells (Blank, si Ctrl and ARK5 si) (Fig. 4) . Remarkably, compared with the Blank and the si Ctrl groups, the expression levels of ARK5, Slug, SIP1 and Vimentin in the ARK5 si group dramatically decreased. Conversely, the expression level of E-cadherin significantly increased. The expression levels of Snail, ZEB1 and Twist didn't significantly varied (Fig. 4) . Since the mTOR signaling pathway is one of the major pathways regulating the migration and invasion of cancer cells [23] . We focused on mTOR/p70S6K (p70S6k, a downstream effector of mTOR) signals. Clearly, a decrease in the levels of p-mTOR and p-p70S6k, but not the total amounts of these proteins, was observed in the ARK5 si group (Fig. 4) . Based on the above results of this section, it was demonstrated that knockdown of ARK5 expression modulated EMT in GC cells, resulting in the down-regulation of the mTOR/ p70S6k signals, Slug and SIP1.
ARK5 promotes GC cells migration and invasion in vitro
To prove the influence of ARK5 reduction on the migration and invasion capacities of GC cells, the transwell chambers and the wound healing assays were used. As shown in Fig.  5a -b, the migratory and invasive activities were significantly impaired in SGC7901 and AGS Table 3 . Spearman relation analysis among expressions of ARK5, E-cadherin and Vimentin in GC tissues 
ARK5 is essential for SGC7901 cells metastasis in vivo
To ascertain whether ARK5 could affect tumor formation in vivo, SGC7901 cells (si Ctrl or ARK5 si) were injected subcutaneously into nude mice. As shown in Fig. 6b , the weight and the volume of tumor were almost identical between the two groups, suggesting that ARK5 was not essential for tumor formation in SGC7901 cells. To determine whether knockdown of ARK5 expression could suppress GC cells metastasis in vivo. SGC7901 cells (si Ctrl or ARK5 si) were injected into the tail vein of nude mice, respectively. The lungs of mice were scanned through Micro PET/CT exposure, and the number of lung metastatic foci was calculated 30 days later. Obviously, the model of lung metastatic foci in nude mice was found to be successfully established through the Micro PET/CT scanning (Fig. 7a) . Afterwards, a significantly less number of lung metastasis foci could be observed in the ARK5 si group compared with the si Ctrl group (Fig. 7b-c) . Furthermore, consistent with the finding in vitro, the expression levels of ARK5 and Vimentin decreased, combined with E-cadherin upregulation, in metastasis nodules in the lungs of the ARK5 si group, by western blot and IHC assays (Fig. 7d-e) . Consequently, these observations suggested that knockdown of ARK5 expression could inhibit GC SGC7901 cells metastasis in vivo.
Discussion
It is interesting to note, that numerous genetic changes are relation to the invasion and metastasis of cancer cells [23, 24] . Hence, in search for key regulators in the metastatic process of GC is very meaningful. AMPK, at present, is already known to act as a tumor suppressor through interacting with a network of complex structures in cancer cells. ARK5, one of members of AMPK family, is considered as be involved in cancer invasion and metastasis as a result of its great sequence homology to the catalytic domain of AMPK [25] . ARK5 was first deemed as a tumor malignancy-associated factor in Akt-induced cell migration activity in human pancreatic and colon cancer cells [13] . As already reported, ARK5, as a downstream substrate of Akt, was directly activated by phosphorylation at its , and therefore resulting in stimulation of cancer cells invasion and metastasis [15] . To date, ARK5 has been confirmed to facilitate cancer metastasis through the induction of EMT or the activation of matrix metalloproteinase 2 (MMP2) and MMP9 in certain human malignancies [20, [26] [27] [28] . However, few investigations about the effect of ARK5 on the GC invasion and metastasis have been reported.
In this study, our data showed that ARK5 was frequently overexpressed in GC tissues, as well as related with clinical metastasis and patient survival, implying that high expression of ARK5 may be a useful diagnostic marker for GC. To better evaluate the potential role of the ARK5 gene in GC invasion and metastasis, we performed recombinant plasmid vectors and transfected it into GC cell lines SGC7901 and AGS. The results revealed that knockdown of ARK5 expression significantly decreased the invasive and metastatic potential of GC cells in vitro and in vivo. Furthermore, in the section of nude mice metastatic model, it is noteworthy that the model construction does not conform to the criterion of physiologic metastatic model. However, as previously reported, this metastatic model has been employed to determine the invasive and metastatic potential of cancer cells [7, 29, 30] , in that this model is capable of imitating the overflow of cancer cells from blood vessels into the target organ, which is considered as a critical step in the metastatic process [31] .
EMT is widely accepted to be closely associated with cancer cells invasion and metastasis [32] . To ascertain whether ARK5 promotes GC cells invasion and metastasis through the induction of EMT, we explored the role of ARK5 in the expression levels of E-cadherin and Vimentin in GC cells. In the light of ARK5 knockdown, E-cadherin expression was upregulated, together with Vimentin expression down-regulated. Besides, ARK5 expression was positively correlated with Vimentin expression in GC tissues, but negatively associated with E-cadherin expression. As a result of these findings, it seems reasonable that the effects of ARK5 on GC cells invasion and metastasis may be attributed to its induction of EMT.
Akt/mTOR/p70S6k signaling pathway is of great importance in the induction of EMT [33, 34] . Our present results showed that down-regulation of mTOR and p70S6k (a downstream mediator of mTOR) phosphorylation was caused by ARK5 (a direct downstream effector of Akt) knockdown. Combined with a previous finding that mTOR was directly phosphorylated by Akt [35] , it seems likely that certain factors modulating mTOR phosphorylation is phosphorylated by ARK5 for mTOR phosphorylation. Perhaps, ARK5 may directly induce mTOR phosphorylation at a site. In view of its essential complexity and greater importance of mTOR pathway, these issues should be further examined in the future. In addition, our data showed the reduction of transcription factors (Slug and SIP1), might contribute EMT owing to the indirect induction of ARK5 knockdown. Collectively, knockdown of ARK5 expression suppresses invasion and metastasis of GC, together with the down-regulation of the mTOR/ p70S6k signals, Slug and SIP1.
In summary, our study demonstrated that the elevated expression level of ARK5 closely correlated with poor pathological characteristics in patients with GC, and that knockdown of ARK5 expression suppressed GC cells invasion and metastasis, coupling with the downregulation of the mTOR/p70S6k signals, Slug and SIP1. Further exploration is nonetheless required to deepen the understanding of the mechanism(s) through which ARK5 facilitates GC cells invasion and metastasis, with the purpose of developing a novel therapeutic target.
